Skip to main content

Table 1 Molecular classification of breast carcinoma [13]

From: The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes

FeatureLuminal ALuminal BHER-2+Basal like
ER/PRPositivePositiveMostly negativeNegative
HER-2NegativeMay be amplifiedAmplifiedNegative
Other markers’ positivityCK 8/18CK 8/18Androgen receptorCK 5/6, EGFR
Proliferation rate (ki67 index)LowIntermediateHighVery high
Recommended therapyHormonalHormonal and chemotherapyHerceptin and chemotherapyChemotherapy
PrognosisFavorableUnfavorablePoorWorst